Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain

Keyphrases

• Polymorphism 100%
• Weight Gain 100%
• Melanocortin 4 Receptor (MC4R) 100%
• Antipsychotics 100%
• Rs17782313 100%
• Second-generation Antipsychotics 57%
• Body Mass Index 28%
• Energy Homeostasis 28%
• Genome-wide Association Study 14%
• Gene Expression 14%
• Risk Factors 14%
• High Risk 14%
• Candidate Gene Study 14%
• Adverse Effects 14%
• Dose Effect 14%
• Clinical Benefit 14%
• Additional Weight 14%
• Pharmacotherapy 14%
• Co-medication 14%
• Risperidone 14%
• Novel Candidate Genes 14%
• Quetiapine 14%
• Atypical Antipsychotics 14%
• Amisulpride 14%
• Antipsychotic Clozapine 14%
• Paliperidone 14%
• Naturalistic Design 14%
• Polygenetic Risk 14%
• Clozapine Olanzapine 14%

Neuroscience

• Melanocortin 4 Receptor 100%
• Receptor Gene 100%
• Antipsychotic 100%
• Body Mass Index 40%
• Adverse Effect 20%
• Atypical Antipsychotic 20%
• Quetiapine 20%
• Risperidone 20%
• Olanzapine 20%
• Amisulpride 20%
• Clozapine 20%
• Paliperidone 20%
• Gene Expression 20%
• Genome-Wide Association Study 20%
• Receptor 20%
• Drug Therapy 20%